Botulinum toxin treatment in the head and neck region : CCCCCurrent aspects, developments, and problems;Botulinumtoxin-Therapie im Kopf-Hals-Bereich : AAAAktuelle Aspekte, Entwicklungen und Probleme

HNO

Volumn 55, Issue 6, 2007, Pages 437-442

  Laskawi, R ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Botulinum toxin treatment; Head and neck region; New developments

Indexed keywords

BOTULINUM TOXIN;

ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL PRACTICE; DRUG EFFECT; GERMANY; HEAD; HEAD AND NECK TUMOR; HEADACHE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; NECK; NECK PAIN; PRACTICE GUIDELINE; WOUND HEALING;

AUTONOMIC NERVOUS SYSTEM DISEASES; BOTULINUM TOXINS; GERMANY; HEAD; HEAD AND NECK NEOPLASMS; HEADACHE; HUMANS; INJECTIONS, INTRAMUSCULAR; NECK; NECK PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; WOUND HEALING;

EID: 34347230888     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-007-1546-4     Document Type: Article

References (31)

1. Bhidayasiri R, Cardoso F, Truong DD (2006) Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin peparations. Eur J Neurol 13(Suppl 1): 21-29
2. Brin MF, Stewart C, Blitzer A, Diamond B (1994) Laryngeal botulinum toxin injections foer disabling stuttering in adults. Neurology 44: 2262-2264
3. Finzi E, Wasserman E (2006) Treatment of depression with botulinum toxin A: a case series. Dermatol Surg 32: 645-649
4. Gassner HG, Sherris DA (2000) Addition of an anesthetic agent to enhance the predictability of the effects of botulinum toxin type A injections: a randomized controlled study. Mayo Clin Proc 75: 701-704
5. Gassner HG, Sherris DA, Otley CC (2000) Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates. Plast Reconstr Surg 105: 1948-1953
6. Gassner H (2004) Combination of botulinum toxin with anaeshetic and vasoconstrictor agent for the treatment of spasmodic dysphonia. Abtract. 5th European congress of oto-rhino-laryngology, head and neck surgery, Rhodos, 11.-16.09.2004, p 9
7. Gassner HG, Brisset AE, Otley CC et al. (2006) Botulinum toxin to improve facial wound healing: A prospective, blinded, placebo-controlled study. Mayo Clin Proc 81: 1023-1028
8. Kruse E, Olthoff A, Schiel R (2006) Functional anatomy of the recurrent and superior laryngeal nerve. Langenbecks Arch Surg 391: 4-8
9. Kubilay U, Unver S, Kaytaz A et al. (2003) Botulinum toxin injections to cricothyroid muscles fpr relief of bilateral recurrent laryngeal nerve paralysis. Turk Arch Otolaryngol 41: 82-87
10. Laskawi R (1998) Die therapeutische Anwendung von Botulinum-Toxin im Hals-Nasen-Ohren-Bereich, Teil 1: Die Behandlung von Bewegungsstö rungen der mimischen Muskulatur. HNO 46:281-287
11. Laskawi R (1998) Die therapeutische Anwendung von Botulinum-Toxin im Hals-Nasen-Ohren-Bereich, Teil 2: Bewegungsstörungen der kraniozervikalen Muskulatur (außer mimischer Muskulatur) sowie Störungen des autonomen Nervensystems. HNO 46: 366-373
12. Laskawi R, Rohrbach S (2005) Operative und konservative Verfahren zur Wiederherstellung der motorischen Funktionen des Nervus facialis, Nervus accessorius, Nervus hypoglossus. Laryngorhinootologie 84(Suppl 1): 142-155
13. Murry T, Wasserman T, Carrau RL, Castillo B (2005) Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol 26: 157-162
14. Olthoff A, Zeiss D, Laskawi R et al. (2005) Laser microsurgical bilateral posterior cordectomy for the treatment of bilateral vocal fold paralysis. Ann Oto Rhinolaryn 114: 599-604
15. Olthoff A, Laskawi R, Kruse E (2007) Successful treatment of autophonia with botulinum toxin: a case report, (in press)
16. Ozcan C,Vayisoglu Y, Dogu O, Gorur K (2006) The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 27: 314-318
17. Rohrbach S, Laskawi R (2001) Minimally invasive application of botulinum toxin type A in nasal hypersecretion. ORL 63: 382-384
18. Rohrbach S, Laskawi R (2003) Use of BTX-A in intrinsic rhinitis. In: Fayaz A, Jost WH (eds) Basic research on botulinum toxin A. Wissenschaftsverlag Wellingbüttel, Hamburg, S 55-61
19. Rohrbach S, Laskawi R (2004) Botulinum-Toxin-Behandlung der Rhinorrhö. In: Laskawi R, Roggenkämper P (Hrsg)"Botulinum-Toxin- Therapie im Kopf-Halsbereich, 2. Aufl. Urban & Vogel, München
20. Rohrbach S, Laskawi R (2004) Praktische Anwendung von Botulinum-Toxin im Kopf-Hals-Bereich. HNO 52: 635-641
21. Rohrbach S, Laskawi R (Hrsg) (2004) Die Anwendung von Botulinum Toxin A in der Hals-Nasen-Ohrenheilkunde. HNO-Praxis heute. Springer, Berlin Heidelberg New York, S 53-76
22. Samton J, Mauskop A (2006) Treatment of headaches with botulinum toxin. Expert Rev Neurother 6: 313-322
23. Schiel RA (Hrsg) (2006) Untersuchungen zur topographischen Anatomie der Kehlkopfnerven und ihrer Ramifizierung. Medizinische Dissertation, Universität Göttingen
24. Scolozzi P, Carrera E, Bertrand J, Kuntzer t (2005) Successful treatment of a postpolio tinnitus with ty A botulinum toxin. Laryngoscope 115:1288-1290
25. Sherris DA, Gassner HG (2002) Botulinum toxin to minimize facial scaring. Facial Plast Surg 18: 35-39
26. Spinelli P, Ballardini G (2003) Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum. Surg Endosc 17:660
27. Stidham KR, Solomon PH, Robersson JB (2005) Evaluation of botulinum toxin A in treatment of tinnitus. Otolaryngol Head Neck Surg 132: 883-889
28. Truong DD, Jost HJ (2006) Botulinum toxin: Clincal use. Parkinsonism Relat Disord 12: 331-355
29. Truong DD, Bhidayasiri R (2006) Botulinum toxin therapy of laryngeal muscle hyperactivity syndrome: comparing different botulinum toxin peparations. Eur J Neural 13(Suppl 1): 36-41
30. Unal M, Sevim S, Dogu O et al. (2003) Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind place-bo-controlled clinical trial. Acta Otolaryngol 123: 1060-1063
31. Wilson AM (2006) Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg 117: 1758-1766